Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction

This article was originally published here

Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol “NLTX” beginning on Monday, August 12, 2019, on the Nasdaq Global

The post Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply